The titration schedule exists to protect you from side effects that make treatment unsustainable
There are some data to suggest that insulin resistance also occurs in PD [70], however, this is controversial since systemic insulin resistance is not present in de novo, medication-free PD patients [71], and brain insulin resistance is not present in cognitively normal PD cases [72]
Reconstituted solution handling
Rob Berberian or another qualified physician regarding any medical condition, medication, or procedure, including GLP-1 receptor agonist therapy
That means patients may not always know what they are getting, he added
16-18 Nausea is the most frequently reported AE among GLP-1 RAs, with rates ranging from 20% to 40% depending on the agent and dose